Visionwave Holdings Inc

This proposal asks stockholders to approve the Company’s 2026 Omnibus Equity Incentive Plan, which authorizes up to 7,000,000 shares for awards to employees, directors and consultants. Management seeks approval because existing share reserves under the 2024 and 2025 Plans are deemed insufficient to support anticipated hiring, retention and incentive needs as VisionWave expands internationally and executes multiple acquisitions. The Plan permits a broad range of award types (options, RSUs, restricted stock, SARs, performance awards, etc.), will be administered by the Board or a committee, and includes standard adjustment, clawback and change-in-control provisions. Awards under the Plan are discretionary, and certain grants (notably contingent option grants to executives) are expressly conditioned on shareholder approval, so approval will enable those contingent awards to vest and be granted. From a governance perspective, the Plan contains anti-repricing protections, limits on individual option grants, and is subject to Board/committee oversight, but it will also dilute existing holders and increase the company’s share reserve. Tax and accounting consequences depend on award types; the Plan is structured to permit incentive stock options where applicable and to comply with Section 409A and Rule 16b-3. The Board’s recommendation to vote FOR is grounded in the need to maintain competitive compensation currency and to align management incentives with stockholder interests, balanced against the dilutionary impacts that shareholders should weigh when voting.

This non-binding advisory proposal asks stockholders to approve the disclosed compensation of the named executive officers, including salaries, bonuses and equity awards. Management frames pay as a tool to attract and retain executives through a mix of base salary, performance-based cash bonuses and multi-year equity awards that align management incentives with long-term stockholder value. The proxy discloses large contingent option grants (including multi-million-share option awards to certain executives that vest upon shareholder approval of an equity plan) and severance/change-in-control protections that could be material to evaluating pay-for-performance. While advisory, the Board and Compensation Committee state they will consider the vote’s outcome when setting future pay; a favorable vote would validate current program design, while a negative vote would signal investor concerns requiring responsive changes. Governance risks to consider include dilution from contingent option grants, potential outsized upside to executives (for example, milestone-based Milestone Option for CEO), and the adequacy of performance metrics and clawbacks; the Plan and agreements include clawback and recoupment language and standard performance-based vesting in certain awards. Investors should weigh the strategic growth and M&A context that management cites as the rationale for aggressive incentive grants against dilution, retention incentives, and alignment of realized pay with sustained company performance. The Board’s recommendation FOR indicates it believes the disclosed arrangements are reasonable and support the company’s growth objectives.

This proposal would authorize a Board-determined reverse stock split of common stock at any ratio up to 1-for-250, exercisable through December 31, 2027. Management’s stated purpose is to increase the per-share price to aid Nasdaq continued listing compliance (including minimum bid requirements), improve perceived marketability and potentially attract a broader investor base. Economically, a reverse split consolidates outstanding shares, does not change proportional ownership except for fractional-share treatment, and will increase authorized-but-unissued shares because the authorized share count is not reduced; that could enable further issuances and has potential anti-takeover implications. Fractional-share treatment is set so that fractional entitlements will be replaced by one whole share as determined by the Board, which may benefit small holders but can create complexity in implementation. The approval standard (majority of outstanding shares) is higher than typical proposals, so abstentions and broker non-votes count against approval; this raises execution risk. Investors should consider potential short-term liquidity impacts, possible adverse market reaction, and whether the proposed flexibility (wide ratio range and extended implementation window) appropriately balances operational needs versus shareholder dilution concerns. The Board recommends FOR on the grounds that the flexibility will allow management to respond to market conditions to promote Nasdaq compliance and long-term value creation.

This proposal requests approval to issue up to 7,000,000 contingent shares to Adrian Holdings S.R.L. as part of an asset purchase for the QuantumSpeed intellectual property; 3,000,000 closing shares were already issued and a $10 million promissory note was delivered at closing. Management prefers shareholder approval so VisionWave retains full ownership of the QuantumSpeed assets rather than transferring a 60% equity interest in the subsidiary to Adrian if approval is not obtained. The Board reviewed an independent valuation and fairness opinion from BDO, which applied a discounted cash flow analysis and concluded the consideration was fair as of the valuation date while acknowledging early-stage technology risks and contingent terms. Key downsides for stockholders include meaningful dilution if shares are issued, credit risk on the $10 million unsecured note, and execution risk tied to development and commercialization of the acquired IP. There is an outside date (approximately October 5, 2026) tied to the contractual timetable, after which fallback equity arrangements would be triggered if approval is not finalized. From a governance perspective, Adrian is reported to be unaffiliated and the transaction was negotiated at arm’s length, but investors should monitor integration execution, potential further financings, and whether the subsidiary equity fallback would materially change the Company’s economics. The Board’s FOR recommendation emphasizes retaining full asset ownership and enabling the contemplated integration of QuantumSpeed into VisionWave’s technology stack.

This proposal seeks shareholder approval to issue the remaining contingent 3,500,000 shares to Dream America under an asset purchase for xClibre, contingent upon both proof-of-concept and Nasdaq Rule 5635 stockholder approval. Management reports that a contractual POC evaluation was conducted over an extended period and concluded xClibre met pre-established performance thresholds, supporting the Board’s determination that the POC condition was satisfied. BDO provided an independent valuation and fairness opinion (discounted cash flow approach, valuing the asset approximately $60.1 million) that the Board considered among other commercial and technical diligence. If shareholders do not approve issuance, the asset purchase agreement provides for transfer of a 60% interest in the subsidiary holding the IP to the seller, which would substantially reduce VisionWave’s ownership and upside from xClibre. Dilution from share issuance is the principal downside, and the number of shares is fixed in this case (3,500,000 contingent shares), so the dilution is more certain than some other transactions; management also issued closing shares and a promissory note as part of the deal. The Board’s FOR recommendation rests on completing the acquisition on the agreed terms, preserving full ownership, and enabling integration and commercialization; investors should weigh the POC results, BDO’s valuation assumptions, and the expected contribution of xClibre to company revenues and product roadmap.

This proposal requests approval for all shares issuable under a three-stage Exchange Agreement with SaverOne, including shares issued to SaverOne in three closings and a separate management share pool, subject to an aggregate economic value ceiling. The staged exchange contemplates up to ~51% ownership of SaverOne by VisionWave across three milestones in exchange for Company stock with an aggregate capped economic value (~$7M to SaverOne plus ~$3M to management for a total economic ceiling near $10M), but the actual number of shares depends on VWAP at each closing and a value-protection mechanism that adjusts share counts inversely to price. Management presents SaverOne as the intended operating platform for the Company’s RF defense/security technologies and the transaction as strategically important to integrate RF IP and operations. The dilution is uncertain and could be significant if VisionWave’s share price declines prior to closings because more shares would be issued to satisfy the dollar-value payments; the Management Share Pool further increases potential dilution. Nasdaq Rule 5635 coverage requires stockholder approval because the aggregate issuances may exceed 20% of outstanding shares; approval enables completion without exchange-cap constraints. Investors should consider strategic benefits of operational consolidation against dilution risk, the terms of the value protection mechanism, governance and control implications at SaverOne, and the impact of any future financings. The Board’s FOR recommendation is premised on the strategic rationale and need for the Nasdaq approval to permit the staged transaction to proceed as structured.

This proposal seeks approval for all shares issued or issuable under the Solar Drone acquisition, including 1,500,000 shares paid at closing and 300,000 initial pre-funded warrants plus any additional pre-funded warrants required if the VWAP at registration below $12 causes entitlement to additional PFWs to preserve the fixed aggregate consideration ($21.6M). Economically the transaction fixes the total consideration value but leaves the share count variable and potentially substantial if VisionWave’s VWAP is low, creating material dilution risk to existing holders. Management’s accounting estimated zero fair value for contingent Additional PFWs as of the acquisition date, but the contingent issuance formula ties the ultimate dilution to market price at registration effectiveness, so investors should consider downside scenarios. Approval is sought under Nasdaq Rule 5635 because the issuance could exceed the 20% exchange cap; without approval the company could not complete the contemplated equity consideration as structured. Strategic rationale includes acquiring Solar Drone’s solar-powered drone technology that may complement VisionWave’s product set, but integration, commercialization and realization of value remain execution risks. The Board supports the proposal to implement the acquisition terms; shareholders should weigh the strategic benefits against dilution and the mechanics of the pre-funded warrants and registration-based triggers.

This proposal asks shareholders to approve a two-stage securities exchange whereby VisionWave would acquire up to 52% of Foresight in exchange for Company common stock valued at $17.5 million plus up to $3.0 million in management equity grants; the number of shares is determined by VWAP-based formulas and a value-protection mechanism that can trigger iterative make-whole share issuances or pre-funded warrants if sale proceeds to Foresight fall below protected thresholds. The transaction is strategic: management contends it will combine VisionWave’s RF sensing and AI capabilities with Foresight’s optical, thermal and stereovision technologies to create an integrated Perception Platform targeting commercial, defense and unmanned systems applications. BDO prepared a fairness opinion and DCF-based valuation supporting the Board’s view that the consideration was fair as of the valuation date, but the opinion includes customary limitations and does not guarantee future trading prices or operational success. Key risks are potentially significant dilution from the make-whole/value-protection mechanism (which protects 65% of the stated consideration during 2-year windows and can require repeated issuances), share-price sensitivity of issued share counts, milestone risk for Stage 2, governance constraints because Foresight remains a separate Israeli public company with minority protections, and integration/execution risk. The Board recommends FOR emphasizing strategic synergies and the need for Nasdaq shareholder approval to permit the exchange as structured; investors should carefully evaluate the potential magnitude and conditionality of dilution, the protections and leak-out limits, and the expected timeline and commercial pathways to capture value from the combined technologies.